C153H225N43O49S
3482.7 g/mol
원료의약품위험
Glucagonum
CAS16941-32-5EC232-708-2
용도 분류
원료의약품
화합물 분류
펩타이드
주요 용도
의약 원료
Glucagonum is a peptide compound used as an active pharmaceutical ingredient in pharmaceutical manufacturing. Its structure is characterized by a large, flexible molecule with multiple amide bonds and polar functional groups.
medication
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 16941-32-5
관련 화합물
강한 관련구조 유사유사도 0.98
Glucagon Impurity 4(DG-2)
CAS1037751-81-7
n.a
강한 관련구조 유사유사도 0.90
Glucagon Impurity 2
CAS75217-63-9
glucagon impurity reference standard
강한 관련구조 유사유사도 0.88
(Des-Thr7)-Glucagon Trifluoroacetate
CAS1802078-28-9
Pharmaceutical intermediate
강한 관련구조 유사유사도 0.87
(Des-Thr5)-Glucagon Trifluoroacetate
CAS1802078-27-8
research compound
참고동일 카테고리
Deracoxib
CAS169590-41-4
selective cyclooxygenase 2 inhibitor
참고동일 카테고리
세레콕시브
CAS169590-42-5
cyclooxygenase 2 inhibitor
참고동일 카테고리
Cortrosyn
CAS16960-16-0
diagnostic aid for adrenal function
참고동일 카테고리
(S)-1-(4-(6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)quinazolin-4-yl)piperazin-1-yl)prop-2-en-1-one
CAS1698024-73-5
covalent KRAS-G12C inhibitor
안전 참조
위험
H317May cause an allergic skin reaction
H332Harmful if inhaled
H334May cause allergy or asthma symptoms or breathing difficulties if inhaled
식별자
IUPAC 이름
(3S)-3-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]-5-oxopentanoyl]amino]-4-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-1,4-dioxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid
InChIKey
MASNOZXLGMXCHN-ZLPAWPGGSA-N
SMILES
C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC7=CN=CN7)N)O
동의어 목록 (47)
- BAQSIMI
- Glucagonum [INN-Latin]
- Human glucagon, European Pharmacopoeia (EP)
- Big plasma glucagon
- Bovine glucagon
- GVOKE HYPOPEN
- Glucagen Hypokit
- Glucagon (1-29)
- Glucagon (Saimiri sciureus)
- Glucagon (Xenopus laevis)
- Glucagon (dog)
- Glucagon (human)
- Glucagon (ox)
- Glucagon (swine)
- Glucagon 1555
- Glucagon Emergency Kit
- Glucagon kit
- Glucagon recombinant
- Glucagon, pig
- Glucagon, porcine
- Glucagone
- Glucagonum
- Glukagon
- Glukagon Novo
- Gvoke Kit
- Gvoke Kit Vial
- Gvoke PFS
- HG-Factor
- Proglucagon (33-61)
- glucagon injection, solution